Matrix Metalloproteinase Expressions in Arteriosclerotic Aneurysmal Disease

Abstract

Medial degeneration of extracellular matrix (ECM) proteins in the wall of abdominal aortas results in smooth muscle cell destruction, a loss of architectural integrity, and abdominal aortic aneurysm (AAA) formation. It has been theorized that an imbalance between proteinases and their naturally occurring inhibitors is the cause of these observed histologic abnormalities. Therefore, the purpose of this investigation was to determine if differences in the matrix metalloproteinase (MMP) -2 and -9, tissue inhibitor of metalloproteinase-1 (TIMP-1), tissue-type plasminogen activator (tPA), and urokinase-type plasminogen activator (uPA) protein and activity levels existed between infrarenal AAA and normal abdominal aortic tissue specimens.

Between November 1995 and January 1997, 10 patients undergoing elective infrarenal AAA repair had a portion of their aneurysm walls snap frozen in liquid nitrogen and processed for subsequent western blot or zymographic analysis. Tissue specimens from 6 normal abdominal aortas obtained from fresh cadaver specimens were similarly processed and served as controls. Protein levels for MMP-2, MMP-9, TIMP-1, uPA, and tPA were analyzed by western blotting. The degree of MMP-2 and MMP-9 gelatinolytic activity was analyzed by zymography. Detection and immunolocalization for MMP-2, MMP-9 and CD68 was performed on tissue sections of AAA and normal infrarenal abdominal aortas fixed in 10% formalin.

MMP-9 and tPA protein levels were increased in AAAs compared to controls by western blotting. However, uPA levels were slightly increased in controls. No differences in TIMP-1 protein levels were identified. Similarly, zymography demonstrated increased MMP-2 and MMP-9 gelatinolytic activity in AAAs compared to controls (p<0.05). CD68-positive cells (macrophages) in the adventitia and media demonstrated immunoreactivity to MMP-9.

This investigation demonstrated increased MMP-9 proteinase activity and tPA protein levels in the walls of AAAs, as well as inflammatory leukocyte invasion of the adventitia and media compared to controls. These data suggest that leukocyte-derived MMP-9 is associated with aortic wall degeneration and aneurysm formation. Furthermore, activation of MMP-9 may be caused by increased tPA levels in the walls of AAAs.

Get full access to this article

View all access options for this article.

References

1. Menashi S . Campa JS , Greenhalgh RM , et al: Collagen in abdominal aortic aneurysm: Typing, content, and degradation. J Vasc Surg 6:578-582, 1987.

2. White JV , Haas K , Phillips S , et al: Adventitial elastolysis is a primary event in aneurysm formation. J Vasc Surg 17:371-381, 1993.

3. Woessner JF Jr : Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154, 1991.

4. Ward RV , Atkinson SJ , Slocombe PM , et al: Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim Biophys Acta 1079:242-246, 1991.

5. Miyazaki K , Funahashi K , Numata Y , et al: Purification and characterization of a two-chain form of tissue inhibitor of metalloproteinases (TIMP) type 2 and a low-molecular-weight TIMP-like protein. J Biol Chem 268:14387-14393, 1993.

6. Kobayashi H , Schmitt M , Goretzki L , et al: Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinasetype plasminogen activator (pro-uPA). J Biol Chem 266:5147-5152, 1991.

7. Zarins CK , Runyon-Hass A , Zatina MA , et al: Increased collagenase activity in early aneurysmal dilatation. J Vasc Surg 3:238-248, 1986.

8. Powell J. , Greenhalgh RM : Cellular, enzymatic, and genetic factors in the pathogenesis of abdominal aortic aneurysms. J Vasc Surg 9:297-304, 1989.

9. Herron GS , Unemori E , Wong M , et al: Connective tissue proteinases and inhibitors in abdominal aortic aneurysms: Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler Thromb 11:1667-1677, 1991.

10.

10. Irizarry E , Newman KM , Gandhi RH , et al: Demonstration of interstitial collagenase in abdominal aortic aneurysm disease. J Surg Res 54:571-574, 1993.

11.

11. Newman KM , Ogata Y , Malon AM , et al: Identification of matrix metalloproteinases 3 (stromelysisn-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb 14:1315-1320, 1994.

12.

12. McMillan WD , Patterson BK , Keen RR , et al: In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. Arterioscler Thromb Vasc Biol 15:1139-1144, 1996.

13.

13. McMillan WD , Patterson BK , Keen RR , et al: In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta. J Vasc Surg 22:295-305, 1995.

14.

14. Thompson RW , Holmes DR , Mertens RA , et al: Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 96:318-326, 1995.

15.

15. Freestone T . Turner RJ , Coady A , et al: Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15:1145-1151, 1995.

16.

16. McMillan WD , Tamarina NA , Cipollone M , et al: Size matters: The relationship between MMP-9 expression and aortic diameter. Circulation 96:2228-2232, 1997.

17.

17. Brophy CM , Marks WH , Reilly JM , et al: Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: A preliminary report. J Surg Res 50:653-657, 1991.

18.

18. Tilson MD , Reilly JM , Brophy CM , et al: Expression and sequence of the gene for tissue inhibitor of metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg 18:266-270, 1993.

19.

19. Knox JB , Sukhova GK , Whitemore AD , et al: Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 95:205-212, 1997.

20.

20. Jean-Claude J , Newman KM , Li H , et al: Possible key for plasmin in the pathogenesis of abdominal aortic aneurysms. Surgery 116:472-478, 1994.

21.

21. Reilly JM , Sicard GA , Lucore CL : Abnormal expression of plasminogen activator in aortic aneurysmal and occlusive disease. J Vasc Surg 19:865-872, 1994.

22.

22. Shireman PK , McCarthy WJ , Pearce WH , et al: Elevation of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta. J Vasc Surg 25:157-164, 1997.

23.

23. Newman KM , Jean-Claude J , Li H , et al: Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg 20:814-820, 1994.

24.

24. Holmes DR , Petrinec D , Wester W , et al: Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. J Surg Res 63:305-309, 1996.

25.

25. Petrinec D , Liao S . Holmes DR , et al: Doxycycline inhibition of aneurysmal degeneration in an elastaseinduced rat model of abdominal aortic elastin associated with suppressed production of 92-kD gelatinase. J Vasc Surg 23:336-346, 1996.

26.

26. Allaire E , Hasenstab D , Kenagy RD , et al: Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-i. Circulation 98:249-255, 1998.